Brolucizumab for Neovascular AMD: The 2 Year HAWK and HARRIER Results

Related

• 

  Ethics in Retina: A Discussion on the Ethical Considerations in Industry Relationships and Informed Consent

  Nancy M. Holekamp, MD, FASRS

  J. Michael Jumper, MD, FASRS

  Paul Chan

  Adrienne W. Scott, MD, FASRS

  Webinars and Journal Clubs

  2017

• 

  Long-term Anti-VEGF Treatment Following Vitrectomy for Endophthalmitis in Patients With Neovascular AMD

  Zofia Anna Nawrocka (vel Michalewska), MD, PhD

  Annual Meeting Talks

  2018

• 

  Types of Strokes Seen in Patients

  Sophie Jane Bakri, MD

  Updates from the Field

  2017